Abeta

amyloid inhibitors

amyloidorg@gmail.com — Thu, 15 Oct 2009 07:47:48 PDT

Amyloid Inhibitors

Raymond SB, Kumar AT, Boas DA, Bacskai BJ. Optimal parameters for near infrared fluorescence imaging of amyloid plaques in Alzheimer's disease mouse models. Phys Med Biol. 2009 Oct 21;54(20):6201-16. Amyloid Inhibitors

Bedrood S, Jayasinghe S, Sieburth D, Chen M, Erbel S, Butler PC, Langen R, Ritzel RA. Annexin A5 Directly Interacts with Amyloidogenic Proteins and Reduces Their Toxicity. Biochemistry. 2009 Oct 8; Amyloid Inhibitors

Hedden T, Van Dijk KR, Becker JA, Mehta A, Sperling RA, Johnson KA, Buckner RL. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci. 2009 Oct 7;29(40):12686-94. Amyloid Inhibitors

Cousins SL, Hoey SE, Stephenson FA, Perkinton MS. AMYLOID PRECURSOR PROTEIN 695 ASSOCIATES WITH ASSEMBLED NR2A-AND NR2B-CONTAINING NMDA RECEPTORS TO RESULT IN THE ENHANCEMENT OF THEIR CELL SURFACE DELIVERY. J Neurochem. 2009 Oct 7; Amyloid Inhibitors

Hoffner G, André W, Vanhoutteghem A, Souès S, Djian P. Transglutaminase-Catalyzed Cross linking in Neurological Disease: from Experimental Evidence to Therapeutic Inhibition. CNS Neurol Disord Drug Targets. 2009 Oct 7; Amyloid Inhibitors

Meyer-Luehmann M, Mielke M, Spires-Jones TL, Stoothoff W, Jones P, Bacskai BJ, Hyman BT. A reporter of local dendritic translocation shows plaque- related loss of neural system function in APP-transgenic mice. J Neurosci. 2009 Oct 7;29(40):12636-40. Amyloid Inhibitors

Yang TT, Hsu CT, Kuo YM. Cell-derived soluble oligomers of human amyloid-beta peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons. J Neural Transm. 2009 Oct 7; Amyloid Inhibitors

Atamna H. Amino acids variations in Amyloid-beta peptides, mitochondrial dysfunction, and new therapies for Alzheimer's disease. J Bioenerg Biomembr. 2009 Oct 6; Amyloid Inhibitors

Wille H, Bian W, McDonald M, Kendall A, Colby DW, Bloch L, Ollesch J, Borovinskiy AL, Cohen FE, Prusiner SB, Stubbs G. Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):16990-5. Amyloid Inhibitors

Price KA, Caragounis A, Paterson BM, Filiz G, Volitakis I, Masters CL, Barnham KJ, Donnelly PS, Crouch PJ, White AR. Sustained Activation of Glial Cell Epidermal Growth Factor Receptor by Bis(thiosemicarbazonato) Metal Complexes Is Associated with Inhibition of Protein Tyrosine Phosphatase Activity. J Med Chem. 2009 Oct 6; Amyloid Inhibitors

Ran C, Xu X, Raymond SB, Ferrara BJ, Neal K, Bacskai BJ, Medarova Z, Moore A. Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-beta Deposits. J Am Chem Soc. 2009 Oct 6; Amyloid Inhibitors

Davis CH, Berkowitz ML. Structure of the Amyloid-beta (1-42) Monomer Absorbed To Model Phospholipid Bilayers: A Molecular Dynamics Study. J Phys Chem B. 2009 Oct 6; Amyloid Inhibitors

Serrano F, Chang A, Hernandez C, Pautler RG, Sweatt JD, Klann E. NADPH oxidase mediates beta-amyloid peptide-induced activation of ERK in hippocampal organotypic cultures. Mol Brain. 2009 Oct 5;2(1):31. Amyloid Inhibitors

Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, Kano M, Ogihara T, Rakugi H, Morishita R. Angiotensin Receptor Blocker Prevented {beta}-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling. Hypertension. 2009 Oct 5; Amyloid Inhibitors

Yang X, Sheng W, He Y, Cui J, Haidekker MA, Sun GY, Lee JC. Secretory phospholipase A2 Type III enhances {alpha}-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity. J Lipid Res. 2009 Oct 5; Amyloid Inhibitors

Jäger S, Leuchtenberger S, Martin A, Czirr E, Wesselowski J, Dieckmann M, Waldron E, Korth C, Koo EH, Heneka M, Weggen S, Pietrzik CU. alpha-secretase mediated conversion of the Amyloid Precursor Protein derived membrane stub C99 to C83 limits Abeta generation. J Neurochem. 2009 Oct 5; Amyloid Inhibitors

Ye JT, Pi RB, Mao XX, Chen XH, Qin J, Xu SW, Liu PQ. Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain. Neuroreport. 2009 Oct 3; Amyloid Inhibitors

Surguchev A, Surguchov A. Conformational diseases: looking into the eyes. Brain Res Bull. 2009 Oct 3; Amyloid Inhibitors

Mancuso M, Calsolaro V, Orsucci D, Siciliano G, Murri L. Is there a primary role of the mitochondrial genome in Alzheimer's disease? J Bioenerg Biomembr. 2009 Oct 2; Amyloid Inhibitors

Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J Bioenerg Biomembr. 2009 Oct 2; Amyloid Inhibitors

Alikhani N, Ankarcrona M, Glaser E. Mitochondria and Alzheimer's disease: amyloid-beta peptide uptake and degradation by the presequence protease, hPreP. J Bioenerg Biomembr. 2009 Oct 2; Amyloid Inhibitors

Taniguchi A. [Development of click peptide: stimuli-responsive precursor producing Alzheimer's disease-related amyloid beta peptide] Yakugaku Zasshi. 2009 Oct;129(10):1227-32. Amyloid Inhibitors

Nakaya T, Kawai T, Suzuki T. Metabolic stabilization of p53 by FE65 in the nuclear matrix of osmotically stressed cells. FEBS J. 2009 Oct 1; Amyloid Inhibitors

Niebroj-Dobosz I, Janik P, Sokolowska B, Kwiecinski H. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol. 2009 Oct 1; Amyloid Inhibitors

Ono M. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains. Chem Pharm Bull (Tokyo). 2009 Oct;57(10):1029-39. Amyloid Inhibitors

Reference: Pub Med Abstracts

Subscribe to Amyloid et.al. by Email

Amyloid Beta Fibrils

amyloidorg@gmail.com — Thu, 15 Oct 2009 04:47:42 PDT

Khan MA, Berti L. Alzheimer's disease affects progenitor cells through aberrant {beta}-catenin signaling. J Neurosci. 2009 Oct 7;29(40):12369-71. PubMed Abstract

Atamna H. Amino acids variations in Amyloid-beta peptides, mitochondrial dysfunction, and new therapies for Alzheimer's disease. J Bioenerg Biomembr. 2009 Oct 6; PubMed Abstract

Davis CH, Berkowitz ML. Structure of the Amyloid-beta (1-42) Monomer Absorbed To Model Phospholipid Bilayers: A Molecular Dynamics Study. J Phys Chem B. 2009 Oct 6; PubMed Abstract

Durazo A, Shaw BF, Chattopadhyay M, Faull KF, Nersissian AM, Valentine JS, Whitelegge JP. Metal-free superoxide dismutase-1 and three different ALS variants share a similar partially unfolded {beta}-barrel at physiological temperature. J Biol Chem. 2009 Oct 5; PubMed Abstract

Surguchev A, Surguchov A. Conformational diseases: looking into the eyes. Brain Res Bull. 2009 Oct 3; PubMed Abstract

Mancuso M, Calsolaro V, Orsucci D, Siciliano G, Murri L. Is there a primary role of the mitochondrial genome in Alzheimer's disease? J Bioenerg Biomembr. 2009 Oct 2; PubMed Abstract

Taniguchi A. [Development of click peptide: stimuli-responsive precursor producing Alzheimer's disease-related amyloid beta peptide] Yakugaku Zasshi. 2009 Oct;129(10):1227-32. PubMed Abstract

Nakaya T, Kawai T, Suzuki T. Metabolic stabilization of p53 by FE65 in the nuclear matrix of osmotically stressed cells. FEBS J. 2009 Oct 1; PubMed Abstract

Göckler N, Jofre G, Papadopoulos C, Soppa U, Tejedor FJ, Becker W. Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. FEBS J. 2009 Oct 1; PubMed Abstract

Subscribe to Amyloid et.al. by Email

Beta Amyloid 1 40: Research Paper Beta Amyloid 1 40

amyloidorg@gmail.com — Mon, 12 Oct 2009 22:59:14 PDT

Beta Amyloid 1 40: Research Paper Beta Amyloid 1 40

Kumar A, Dogra S, Prakash A. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats. Behav Brain Res. 2009 Dec 28;205(2):384-90. PubMed Abstract

Harrison FE, Hosseini AH, Dawes SM, Weaver S, May JM. Ascorbic acid attenuates scopolamine-induced spatial learning deficits in the water maze. Behav Brain Res. 2009 Dec 28;205(2):550-8. PubMed Abstract

Abbas T, Faivre E, Hölscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behav Brain Res. 2009 Dec 14;205(1):265-71. PubMed Abstract

Schulte EC, Slawik H, Schüle R, Gunther T, Hüll M. Alterations in excitotoxicity and prostaglandin metabolism in a transgenic mouse model of Alzheimer's disease. Neurochem Int. 2009 Dec;55(7):689-96. PubMed Abstract

Quiroz-Baez R, Rojas E, Arias C. Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of alpha-, beta- and gamma-secretase expression. Neurochem Int. 2009 Dec;55(7):662-70. PubMed Abstract

Nunes AF, Montero M, Franquinho F, Santos SD, Malva J, Zimmer J, Sousa MM. Transthyretin knockout mice display decreased susceptibility to AMPA-induced neurodegeneration. Neurochem Int. 2009 Dec;55(7):454-7. PubMed Abstract

Hua X, Lee S, Yanovsky I, Leow AD, Chou YY, Ho AJ, Gutman B, Toga AW, Jack CR, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage. 2009 Dec;48(4):668-81. PubMed Abstract

Milton NG, Harris JR. Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding. Micron. 2009 Dec;40(8):800-10. PubMed Abstract

Braun A, Dang J, Johann S, Beyer C, Kipp M. Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins. Neurochem Int. 2009 Dec;55(7):610-8. PubMed Abstract

Riedel G, Kang SH, Choi DY, Platt B. Scopolamine-induced deficits in social memory in mice: reversal by donepezil. Behav Brain Res. 2009 Dec 1;204(1):217-25. PubMed Abstract

Arrázola MS, Varela-Nallar L, Colombres M, Toledo EM, Cruzat F, Pavez L, Assar R, Aravena A, González M, Montecino M, Maass A, Martínez S, Inestrosa NC. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. J Cell Physiol. 2009 Dec;221(3):658-67. PubMed Abstract

Miller EA, Rosenheck RA, Schneider LS. Assessing the Relationship between Health Utilities, Quality of Life, and Health Care Costs in Alzheimer's Disease: The CATIE-AD Study. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Gorham P, Bark N, Björkhem , Meaney S, Crisby M. Platelet Alpha- and Beta- Secretase Activities are not significantly affected by Dementia or Mild Cognitive Impairment in Swedish Patients. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Vestergaard M, Hamada T, Morita M, Takagi M. Cholesterol, Lipids, Amyloid Beta, and Alzheimer's. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Zhang C, Browne A, Kim DY, Tanzi RE. Familial Alzheimer's Disease Mutations in Presenilin 1 Do Not Alter Levels of the Secreted Amyloid-beta Protein Precursor Generated by beta-Secretase Cleavage. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Shytle RD, Bickford PC, Rezai-Zadeh K, Houb L, Zeng J, Tana J, Sanberg PR, Sanberg CD, Roschek B, Fink RC, Alberte RS. Optimized Turmeric Extracts Have Potent Anti-amyloidogenic Effects. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Xue S, Jia L, Jia J. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population. Neurosci Lett. 2009 Nov 13;465(2):181-3. PubMed Abstract

Lomoio S, Scherini E, Necchi D. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice. Brain Res. 2009 Nov 10;1297:198-206. PubMed Abstract

Hashimoto Y, Kurita M, Matsuoka M. Identification of soluble WSX-1 not as a dominant-negative but as an alternative functional subunit of a receptor for an anti-Alzheimer's disease rescue factor Humanin. Biochem Biophys Res Commun. 2009 Nov 6;389(1):95-9. PubMed Abstract

Li M, Inaba M, Guo K, Abraham NG, Ikehara S. Amelioration of cognitive ability in senescence-accelerated mouse prone 8 (SAMP8) by intra-bone marrow-bone marrow transplantation. Neurosci Lett. 2009 Nov 6;465(1):36-40. PubMed Abstract

Levine H, Ding Q, Walker JA, Voss RS, Augelli-Szafran CE. Clioquinol and other hydroxyquinoline derivatives inhibit Abeta(1-42) oligomer assembly. Neurosci Lett. 2009 Nov 6;465(1):99-103. PubMed Abstract

Harris B, Pereira I, Parkin E. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Brain Res. 2009 Nov 3;1296:203-15. PubMed Abstract

Uno Y, Iwashita H, Tsukamoto T, Uchiyama N, Kawamoto T, Kori M, Nakanishi A. Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice. Brain Res. 2009 Nov 3;1296:148-63. PubMed Abstract

Juusela P, Tanskanen M, Nieminen A, Uitto VJ, Blåfield H, Kiuru-Enari S. Hereditary gelsolin amyloidosis mimicking Sjögren's syndrome. Clin Rheumatol. 2009 Nov;28(11):1351-4. PubMed Abstract

Baumgartner R, Meder G, Briand C, Decock A, D'arcy A, Hassiepen U, Morse R, Renatus M. The crystal structure of caspase-6, a selective effector of axonal degeneration. Biochem J. 2009 Nov 1;423(3):429-39. PubMed Abstract

Subscribe to Amyloid et.al. by Email

Beta Amyloid 1 28: Research Paper on Beta Amyloid 1 28

amyloidorg@gmail.com — Mon, 12 Oct 2009 08:04:57 PDT

Beta Amyloid 1 28: Research Paper on Beta Amyloid 1 28

Milton NG, Harris JR. Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding. Micron. 2009 Dec;40(8):800-10. PubMed Abstract

Riedel G, Kang SH, Choi DY, Platt B. Scopolamine-induced deficits in social memory in mice: reversal by donepezil. Behav Brain Res. 2009 Dec 1;204(1):217-25. PubMed Abstract

Vestergaard M, Hamada T, Morita M, Takagi M. Cholesterol, Lipids, Amyloid Beta, and Alzheimer's. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Goldknopf IL, Bryson JK, Strelets I, Quintero S, Sheta EA, Mosqueda M, Park HR, Appel SH, Shill H, Sabbagh M, Chase B, Kaldjian E, Markopoulou K. Abnormal serum concentrations of proteins in Parkinson's disease. Biochem Biophys Res Commun. 2009 Nov 13;389(2):321-7. PubMed Abstract

Xue S, Jia L, Jia J. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population. Neurosci Lett. 2009 Nov 13;465(2):181-3. PubMed Abstract

Shin KY, Lee JY, Won BY, Jung HY, Chang KA, Koppula S, Suh YH. BT-11 is effective for enhancing cognitive functions in the elderly humans. Neurosci Lett. 2009 Nov 13;465(2):157-9. PubMed Abstract

Moisse K, Mepham J, Volkening K, Welch I, Hill T, Strong MJ. Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL-/- mice: support for a role for TDP-43 in the physiological response to neuronal injury. Brain Res. 2009 Nov 3;1296:176-86. PubMed Abstract

Subscribe to Amyloid et.al. by Email

Structure Of Beta Amyloid: Research Paper on Structure Of Beta Amyloid

amyloidorg@gmail.com — Mon, 12 Oct 2009 23:00:34 PDT

Structure Of Beta Amyloid: Research Paper on Structure Of Beta Amyloid

Piguet O, Garner B. Vascular Pharmacotherapy and Dementia. Curr Vasc Pharmacol. 2010 Jan 1; PubMed Abstract

Bode FJ, Stephan M, Wiehager S, Nguyen HP, Björkqvist M, von Hörsten S, Bauer A, Petersén A. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model. Behav Brain Res. 2009 Dec 14;205(1):175-82. PubMed Abstract

Kiefer C, Brockhaus L, Cattapan-Ludewig K, Ballinari P, Burren Y, Schroth G, Wiest R. Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: the impact of quantitative magnetization transfer MR imaging. Neuroimage. 2009 Dec;48(4):657-67. PubMed Abstract

Wildsmith KR, Han B, Bateman RJ. Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry. Anal Biochem. 2009 Dec 1;395(1):116-8. PubMed Abstract

Milton NG, Harris JR. Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding. Micron. 2009 Dec;40(8):800-10. PubMed Abstract

Nikolaus S, Antke C, Müller HW. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia. Behav Brain Res. 2009 Dec 1;204(1):1-31. PubMed Abstract

Riedel G, Kang SH, Choi DY, Platt B. Scopolamine-induced deficits in social memory in mice: reversal by donepezil. Behav Brain Res. 2009 Dec 1;204(1):217-25. PubMed Abstract

Borroni B, Costanzi C, Padovani A. Genetic Susceptibility to Behavioural and Psychological Symptoms in Alzheimer Disease. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Vestergaard M, Hamada T, Morita M, Takagi M. Cholesterol, Lipids, Amyloid Beta, and Alzheimer's. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Sabbagh MN, Cooper K, Justin Delange D, Stoehr JD, Thind K, Tyson Lahti R, Reisberg B, Sue L, Vedders L, Fleming SR, Thomas P, Beach G. Functional, Global and Cognitive Decline Correlates to Accumulation of Alzheimer's Pathology in MCI and AD. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Angelucci F, Spalletta G, Di Iulio F, Ciaramella A, Salani F, Colantoni L, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Bossù P. Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Guo L, Duggan J, Cordeiro MF. Alzheimer's Disease and Retinal Neurodegeneration. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Subscribe to Amyloid et.al. by Email

Intracellular Amyloid: Research Paper on Intracellular Amyloid

amyloidorg@gmail.com — Mon, 12 Oct 2009 23:01:48 PDT

Intracellular Amyloid: Research Paper on Intracellular Amyloid

Milton NG, Harris JR. Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding. Micron. 2009 Dec;40(8):800-10. PubMed Abstract

Vestergaard M, Hamada T, Morita M, Takagi M. Cholesterol, Lipids, Amyloid Beta, and Alzheimer's. Curr Alzheimer Res. 2009 Dec 1; PubMed Abstract

Bierhaus A, Nawroth PP. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia. 2009 Nov;52(11):2251-63. PubMed Abstract

Edison P, Brooks DJ, Turkheimer FE, Archer HA, Hinz R. Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility. Neuroimage. 2009 Nov 1;48(2):329-38. PubMed Abstract

Ramírez CM, González M, Díaz M, Alonso R, Ferrer I, Santpere G, Puig B, Meyer G, Marin R. VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease. Mol Cell Neurosci. 2009 Nov;42(3):172-83. PubMed Abstract

Squitti R, Zito G. Anti-copper Therapies in Alzheimer's Disease: New Concepts. Recent Pat CNS Drug Discov. 2009 Nov 1; PubMed Abstract

Lin MS, Chen XB, Wang SS, Chang Y, Chen WY. Dynamic fluorescence imaging analysis to investigate the cholesterol recruitment in lipid monolayer during the interaction between beta-amyloid (1-40) and lipid monolayers. Colloids Surf B Biointerfaces. 2009 Nov 1;74(1):59-66. PubMed Abstract

Juusela P, Tanskanen M, Nieminen A, Uitto VJ, Blåfield H, Kiuru-Enari S. Hereditary gelsolin amyloidosis mimicking Sjögren's syndrome. Clin Rheumatol. 2009 Nov;28(11):1351-4. PubMed Abstract

Hall D, Edskes H. A model of amyloid's role in disease based on fibril fracture. Biophys Chem. 2009 Nov;145(1):17-28. PubMed Abstract

Carro EM. Therapeutic Approaches of Leptin in Alzheimer's Disease. Recent Pat CNS Drug Discov. 2009 Nov 1; PubMed Abstract

Zhang JJ, Zhang RF, Meng XK. Protective effect of pyrroloquinoline quinone against Abeta-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci Lett. 2009 Oct 30;464(3):165-9. PubMed Abstract

Mouton PR, Chachich ME, Quigley C, Spangler E, Ingram DK. Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice. Neurosci Lett. 2009 Oct 30;464(3):184-7. PubMed Abstract

Giuliani F, Vernay A, Leuba G, Schenk F. Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism. Brain Res Bull. 2009 Oct 28;80(4-5):302-8. PubMed Abstract

Beeler N, Riederer BM, Waeber G, Abderrahmani A. Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes. Brain Res Bull. 2009 Oct 28;80(4-5):274-81. PubMed Abstract

Rossi D, Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull. 2009 Oct 28;80(4-5):224-32. PubMed Abstract

Subscribe to Amyloid et.al. by Email

Amyloid Beta Dimers: Research Paper: Amyloid Beta Dimers

amyloidorg@gmail.com — Mon, 12 Oct 2009 23:02:58 PDT

Amyloid Beta Dimers: Research Paper : Amyloid Beta Dimers

Bhak G, Choe YJ, Paik SR. Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation. BMB Rep. 2009 Sep 30;42(9):541-51. PubMed Abstract

Alboni S, Cervia D, Ross B, Montanari C, Gonzalez AS, Sanchez-Alavez M, Marcondes MC, De Vries D, Sugama S, Brunello N, Blom J, Tascedda F, Conti B. Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain. J Neuroimmunol. 2009 Sep 29;214(1-2):43-54. PubMed Abstract

Sim PL, Heese K. Ligand-Dependent Activation of the Chimeric Tumor Necrosis Factor Receptor-Amyloid Precursor Protein (APP) Reveals Increased APP Processing and Suppressed Neuronal Differentiation. Neurosignals. 2009 Sep 29;18(1):9-23. PubMed Abstract

Jozefowski S, Marcinkiewicz J. Aggregates of denatured proteins stimulate nitric oxide and superoxide production in macrophages. Inflamm Res. 2009 Sep 26; PubMed Abstract

Han F, Fukunaga K. beta-Amyloid Accumulation in Neurovascular Units Following Brain Embolism. J Pharmacol Sci. 2009 Sep 26; PubMed Abstract

Smach MA, Charfeddine B, Ben Othman L, Lammouchi T, Dridi H, Nafati S, Ltaief A, Bennamou S, Limem K. Evaluation of Cerebrospinal Fluid Tau/Beta-Amyloid(42) Ratio as Diagnostic Markers for Alzheimer Disease. Eur Neurol. 2009 Sep 26;62(6):349-355. PubMed Abstract

Mlekusch R, Humpel C. Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid(1-42) levels. Neurosci Lett. 2009 Sep 26; PubMed Abstract

Colell A, Fernández A, Fernández-Checa JC. Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease. J Bioenerg Biomembr. 2009 Sep 26; PubMed Abstract

Pandey NR, Sultan K, Twomey E, Sparks DL. Phospholipids Block NF-kappaB and Tau Phosphorylation and Inhibit Amyloid-beta Secretion in Human Neuroblastoma Cells. Neuroscience. 2009 Sep 26; PubMed Abstract

Damante CA, O?sz. Metal Loading Capacity of Abeta N-Terminus: a Combined Potentiometric and Spectroscopic Study of Zinc(II) Complexes with Abeta(1-16), Its Short or Mutated Peptide Fragments and Its Polyethylene Glycol-ylated Analogue. Inorg Chem. 2009 Sep 25; PubMed Abstract

Vetri V, Carrotta R, Picone P, Di Carlo M, Militello V. Concanavalin A aggregation and toxicity on cell cultures. Biochim Biophys Acta. 2009 Sep 25; PubMed Abstract

Fonseca AC, Resende R, Oliveira CR, Pereira CM. Cholesterol and statins in Alzheimer's disease: Current controversies. Exp Neurol. 2009 Sep 25; PubMed Abstract

Garringer HJ, Murrell J, D'Adamio L, Ghetti B, Vidal R. Modeling familial British and Danish dementia. Brain Struct Funct. 2009 Sep 25; PubMed Abstract

Hebda JA, Saraogi I, Magzoub M, Hamilton AD, Miranker AD. A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes. Chem Biol. 2009 Sep 25;16(9):943-50. PubMed Abstract

Xiao L, Zhao D, Chan WH, Choi MM, Li HW. Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots. Biomaterials. 2009 Sep 25; PubMed Abstract

Hatip FF, Suenaga M, Yamada T, Matsunaga Y. Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Abeta40, by the beta-sheet breaker peptides 16-23 and 17-24. Br J Pharmacol. 2009 Sep 25; PubMed Abstract

Folwell J, Cowan CM, Ubhi KK, Shiabh H, Newman TA, Shepherd D, Mudher A. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Exp Neurol. 2009 Sep 24; PubMed Abstract

Wright JW, Harding JW. The brain RAS and Alzheimer's disease. Exp Neurol. 2009 Sep 24; PubMed Abstract

Nie J, Luo Y, Huang XN, Gong QH, Wu Q, Shi JS. Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of beta-secretase in rat hippocampus. Eur J Pharmacol. 2009 Sep 24; PubMed Abstract

Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM. Amyloid-{beta} Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle. Science. 2009 Sep 24; PubMed Abstract

Hernández F, Gómez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J. GSK3: A possible link between beta amyloid peptide and tau protein. Exp Neurol. 2009 Sep 24; PubMed Abstract

Sultana R, Butterfield DA. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J Bioenerg Biomembr. 2009 Sep 24; PubMed Abstract

Gliebus G, Rosso A, Lippa CF. Progranulin and B-Amyloid Distribution: A Case Report of the Brain From Preclinical PS-1 Mutation Carrier. Am J Alzheimers Dis Other Demen. 2009 Sep 23; PubMed Abstract

Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J Neurosci. 2009 Sep 23;29(38):11982-92. PubMed Abstract

Akasaka-Manya K, Manya H, Sakurai Y, Wojczyk BS, Kozutsumi Y, Saito Y, Taniguchi N, Murayama S, Spitalnik SL, Endo T. Protective effect of N-glycan bisecting GlcNAc residues on {beta}-amyloid production in Alzheimer's disease. Glycobiology. 2009 Sep 23; PubMed Abstract

Subscribe to Amyloid et.al. by Email

Tau :Beta Amyloid::Research Paper on Tau Beta Amyloid

amyloidorg@gmail.com — Mon, 12 Oct 2009 23:04:30 PDT

Tau :Beta Amyloid:::: Research Paper on Tau Beta Amyloid

Bhak G, Choe YJ, Paik SR. Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation. BMB Rep. 2009 Sep 30;42(9):541-51. PubMed Abstract

Whitwell JL, Jack CR, Boeve BF, Senjem ML, Baker M, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Rademakers R, Josephs KA. Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology. 2009 Sep 29;73(13):1058-65. PubMed Abstract